Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for Recovery After Abdominal Surgery
NCT02463812Withdrawn
- Sponsor
- University of Alberta
- Start
- May 2015
- Primary completion
- Apr 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Intralipid 10% in postoperative recovery, sponsored by University of Alberta. Primary endpoints: Change in blood pressure at discharge from PACU at 2 hours and Change in respiration rate at discharge from PACU at 2 hours. Planned start May 2015; status: withdrawn.
02
Drugs
Intralipid 10%
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on NCT02463812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463812.